How Much Mobocertinib for NSCLC Exon 20 Mutation?

So, mobocertinib is a inhibitor that goes after the Epidermal Growth Factor Receptor, or EGFR. It’s used to treat a type of lung cancer, specifically NSCLC, that has a certain kind of mutation in the EGFR called exon 20 insertion. The idea behind this drug is to stop cancer cells from growing by blocking the EGFR.

You’ll find it in the form of 40 mg capsules. The doc usually says to take 160 mg of this once a day. It doesn’t matter if you have it with food or not.

Each bottle holds 90 of those 40 mg capsules.